NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $236,433 | +0.9% | 2,321 | 0.0% | 0.05% | +4.5% |
| Q2 2023 | $234,228 | +9.0% | 2,321 | -0.7% | 0.04% | +2.3% |
| Q1 2023 | $214,967 | +3.1% | 2,337 | +1.7% | 0.04% | -4.4% |
| Q4 2022 | $208,434 | +3.7% | 2,298 | -3.2% | 0.04% | -13.5% |
| Q2 2022 | $201,000 | -16.9% | 2,373 | -13.9% | 0.05% | -7.1% |
| Q1 2022 | $242,000 | -4.3% | 2,755 | -4.8% | 0.06% | -3.4% |
| Q4 2021 | $253,000 | +24.6% | 2,893 | +30.1% | 0.06% | +5.5% |
| Q2 2021 | $203,000 | -14.3% | 2,224 | -19.9% | 0.06% | -22.5% |
| Q1 2021 | $237,000 | -30.1% | 2,776 | -22.7% | 0.07% | -35.5% |
| Q4 2020 | $339,000 | +25.1% | 3,593 | +3.5% | 0.11% | +7.8% |
| Q3 2020 | $271,000 | -12.6% | 3,473 | -2.3% | 0.10% | -19.0% |
| Q2 2020 | $310,000 | +4.0% | 3,553 | +6.9% | 0.13% | -3.8% |
| Q1 2020 | $298,000 | -3.2% | 3,323 | +2.3% | 0.13% | +15.9% |
| Q4 2019 | $308,000 | – | 3,249 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |